STATES CHRONICLE – On April 7, the New Mexico Medical Cannabis Advisory Board voted to suggest the state Department of Health adds six more conditions to the list of symptoms. These ailments are bound to qualify individuals to sign up for the medical marijuana program. Moreover, the Cannabis Advisory Board indicated that the state department should increase the strength and the quantity of marijuana a person can possess.
The Cannabis Advisory Board recommended new conditions to be introduced on the list of ailments
The symptoms and conditions which can appear after consuming marijuana include tremors, a neurological condition that causes muscle spasms, dystonia, sleep disorder, migraines, chronic headaches, depression, anxiety, autism, attention deficit hyperactivity disorder. Nevertheless, nobody knows when these changes can occur, their intensity or how long they will last.
Lynn Gallagher, the Health Secretary, who is entitled to have the final word about on modifications to the Medical Cannabis Program, is not yet sure whether she should consider new symptoms recommended by the board back in November. These ailments include an opiate use of disorder and Alzheimer’s disease. The program list contains 20 qualifying diseases.
The new disorder could include Alzheimer’s disease and an opiate use
On April 7, advisory members of the board expressed their disappointment regarding Gallagher’s delay to review and rule on the program changes which were proposed. Dr. Laura Brown, a board member, stated that she believes Gallagher’s attitude is unacceptable. She also argued that it is frustrating that they do not receive an immediate answer from Gallagher after all the efforts they have done.
David Morgan, the spokesman for the Health Department, stated that Gallagher did not take any attitude regarding the recommendations of the board sent last November because lawmakers proposed the implementation of some legislative changes to the Medical Cannabis Program in the recent session. Morgan claimed that after Gallagher had received the recommendations, it was obvious that lawmakers intended to propose several changes to the Medical Cannabis Program.
Gallagher assessed those bills while also considering the recommendations of the board under advisement. Morgan also argued that the main purpose of the Medical Cannabis Program is to assure patients that they have safe access to medical treatments. Probably, it is not easy for the secretary to add new conditions on the list. Morgan refused to speculate how long it will take Gallagher to decide on the pending proposals.
Image source: public domain